Lead
New analysis through 2023 shows colorectal cancer has become the top cause of cancer death for Americans under 50, reversing decades of overall declines in young-adult cancer mortality. The study, published in JAMA and led by researchers at the American Cancer Society, finds deaths from colon and rectal cancers in the under-50 group rose an average of 1.1% per year since 2005. From 1990 to 2023 more than 1.2 million people under 50 died of cancer, but the overall death rate fell by 44% while colorectal deaths increased. Experts are urging earlier screening uptake and faster evaluation of symptoms to counter a rise now concentrated in younger cohorts.
Key Takeaways
- Colorectal cancer became the leading cause of cancer death among U.S. adults under 50 as of 2023, according to a JAMA-published analysis of national mortality data.
- Deaths from colon and rectal cancer in people younger than 50 rose by 1.1% per year since 2005, contrasting with declines in other major cancers.
- Between 1990 and 2023, more than 1.2 million Americans under 50 died of cancer; the aggregate death rate declined 44% over that period.
- Average annual mortality declines (2014–2023) were 5.7% for lung cancer, 2.3% for leukemia, 1.4% for breast cancer and 0.3% for brain cancer.
- Only about 37% of adults aged 45–49 are up to date with colorectal screening, though screening is recommended to begin at 45 for average-risk people.
- Approximately 60 new colorectal cancer diagnoses occur daily in Americans under 50 — roughly one every 25 minutes, per the Colorectal Cancer Alliance.
- More than 60% of colorectal patients under 50 are estimated to be diagnosed at stage 3 or 4, increasing the likelihood of poorer outcomes.
Background
Over the last three decades, advances in prevention, early detection and treatment pushed down mortality for most common cancers across age groups. Public-health campaigns, tobacco control and improvements in systemic therapy drove especially steep declines in lung, breast and leukemia deaths. Yet a reversal has been emerging for colorectal disease in younger cohorts born since the mid-20th century, prompting scrutiny of environmental, behavioral and biological contributors.
Screening practice changed in recent years: professional guidelines moved the routine starting age to 45 for average-risk adults, reflecting rising incidence in younger people. Despite that change, screening coverage among 45–49-year-olds remains low, and many younger patients are diagnosed only after symptoms prompt evaluation. Stakeholders include clinicians, public-health agencies, advocacy groups and researchers seeking to pinpoint causes and to expand prevention and diagnostic pathways.
Main Event
The new study used U.S. death-certificate data from the National Center for Health Statistics to calculate annual counts and rates of cancer deaths among people younger than 50 between 1990 and 2023. Investigators ranked the top five causes of cancer death for that age group and tracked trends over time. By 2023 colorectal cancer had overtaken other sites to sit at the top of that list.
Authors report that while overall cancer mortality in under-50s declined substantially from 1990 to 2023, colon and rectal cancer deaths rose at an average of 1.1% per year beginning in 2005. That increase shifted the relative burden: colorectal cancer moved from the fifth most common cause of cancer death among under-50s in the early 1990s to first place by 2023.
Clinical voices and patient stories underscore how the trend plays out in practice. Jenna Scott, diagnosed at age 31 with stage 4 colon cancer that metastasized to her liver, recounts persistent abdominal pain first dismissed during pregnancy and a later diagnosis that required surgery, chemotherapy and targeted agents. Now 39, she remains on ongoing therapy; her case exemplifies how young, otherwise healthy adults can present with advanced disease.
Investigators and clinicians note that symptom dismissal, delayed diagnostic workups and low screening uptake in the 45–49 window contribute to later-stage presentations. For many under-45 patients, lack of routine screening means diagnosis occurs only after symptoms appear, by which time tumors are often more advanced.
Analysis & Implications
The rise in colorectal mortality among young adults has several potential drivers — none yet confirmed — including shifts in lifestyle, obesity prevalence, dietary patterns, microbiome changes, and unknown cohort-specific exposures. Researchers emphasize that the cause is likely multifactorial and may reflect interactions between environment, behavior and biology in generations born since 1950.
Clinically, the pattern increases the urgency of two responses: raising screening uptake in the 45–49 age group and reducing delays in evaluating symptoms at any age. Screening methods that detect and remove precancerous polyps can both prevent cancer and detect early-stage disease, so improving access and adherence could blunt future mortality trends.
Economically and systemically, more young patients with advanced colorectal cancer will raise treatment costs and long-term survivorship needs, including prolonged systemic therapy, surgical care and supportive services. Payors, health systems and employers may see rising financial and workforce impacts if trends continue unchecked.
From a research standpoint, the findings argue for targeted funding to study etiologic causes in younger cohorts, to refine risk stratification, and to develop strategies that expedite diagnosis for symptomatic younger adults. Policymakers will need to balance resource allocation between prevention, screening expansion and diagnostic capacity.
Comparison & Data
| Cancer site | Average annual change in deaths (2014–2023) |
|---|---|
| Colorectal | +1.1% (since 2005; leading cause by 2023) |
| Lung | −5.7% |
| Leukemia | −2.3% |
| Breast | −1.4% |
| Brain | −0.3% |
Context: the table summarizes reported average annual mortality changes for the five leading cancer causes among under-50s. While lung, leukemia, breast and brain cancers show declines over the recent decade, colorectal cancer is the sole site with increasing deaths, reversing prior patterns and elevating its rank among younger patients.
Reactions & Quotes
Researchers and clinicians described the results as a clear signal warranting action. The senior author at the American Cancer Society emphasized the need for intensified research and greater screening uptake among those aged 45–49.
“We don’t know why it is increasing — we must double down on research to pinpoint what is driving this tsunami of cancer in generations born since 1950.”
Dr. Ahmedin Jemal, American Cancer Society (senior author)
Frontline clinicians highlighted diagnostic delays as a preventable contributor to advanced-stage presentation and urged providers to take symptoms in younger patients seriously.
“There is a tremendous gap — and opportunity — in expeditiously diagnosing and treating people who are already symptomatic.”
Dr. Y. Nancy You, MD Anderson Cancer Center (clinician-researcher)
Patient advocates stressed the human costs: young patients and families face prolonged treatment, disrupted life plans and uncertain long-term outcomes when diagnosis occurs at late stages.
“I was healthy and athletic; in an instant my life changed. We have to stop this increase in mortality.”
Jenna Scott, patient advocate
Unconfirmed
- No definitive cause has been established for the rising colorectal mortality in people born since 1950; suggested explanations remain hypotheses requiring further study.
- Reports on the proportion of cases tied to specific lifestyle or environmental exposures are preliminary and not yet causally confirmed.
- Estimates of how quickly expanded screening would reduce mortality in younger cohorts depend on uptake scenarios and require modeling beyond the current descriptive analysis.
Bottom Line
The JAMA analysis signals a concerning shift: while overall cancer deaths in Americans under 50 have fallen dramatically since 1990, colorectal cancer deaths have risen and now top the list for this age group. This divergence highlights gaps in prevention, screening uptake and timely diagnosis that are actionable today.
Practical steps include improving screening coverage for 45–49-year-olds, educating clinicians and the public to avoid dismissing symptoms in younger patients, and directing research funding to uncover causes underlying the increase. Without coordinated action, the social and health-system burdens of early-onset colorectal cancer are likely to grow.
Sources
- CNN — (news report summarizing the study and patient perspectives)
- JAMA (Journal of the American Medical Association) — (peer-reviewed medical journal; study publication)
- American Cancer Society — (research group/analysis and commentary)
- CDC National Center for Health Statistics — (official U.S. mortality data source)
- Colorectal Cancer Alliance — (advocacy organization; incidence and patient resources)
- MD Anderson Cancer Center — (academic medical center commentary)
- Memorial Sloan Kettering Cancer Center — (academic medical center commentary)